• EN
    • SV
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
  • EN
  • SV
INVESTORS

Events and
Presentations

Saniona Icon blue
  • Overview
  • The Share
    • Share Information
    • Ownership Structure
  • Financial Calendar
  • Reports & Fillings
    • Annual & Quarterly Reports
    • Prospectus
    • Old prospectus
  • Analysts
  • Events and Presentations
  • FAQs
  • Corporate governance
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Shareholder Meetings
    • Nomination Committee
    • Auditors
    • Remuneration Incentive Programs

Corporate Presentation

Corporate Presentation (May 2026)

Upcoming Events

BIO International Convention (San Diego)
June 22, 2026 - June 25, 2026
Affärsvärlden Börsdagarna (Stockholm)
September 15, 2026 - September 15, 2026
BIO-Europe Fall 2026 (Cologne)
November 9, 2026 - November 11, 2026

Past Events

Global Neuro-2022
November 3, 2022
Bio-Europe 2022
October 24, 2022 - October 26, 2022
Redeye Theme: Neurology
October 12, 2022
Webcast Link
ØU Life Science Investor Conference (in Danish)
September 28, 2022
Webcast Link
Aktieinfo Investorarrangement
September 22, 2022
Webcast Link
Aktiespararna Småbolagsdagarna
June 14, 2022
Webcast Link
Redeye Growth Day
June 2, 2022 at 8:45 PM EDT
Webcast Link
Aktiespararna Digital
May 30, 2022 at 6:30 PM CEST
Webcast Link
ABGSC Life Science Summit
May 19, 2022 at 2:00 PM CEST
Webcast Link
Aktieportföljen Live
May 10, 2022 at 8:45 AM EST
Webcast Link
  • « Previous
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next »
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
DENMARK

Murervangen 42
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2026 Saniona. All rights reserved.

Privacy Policy